Skip to main content
European Commission logo print header

Evaluation of the technical, commercial and patent issues regarding the use of human albumin micro-capsules containing iron oxides for magnetic resonance imaging (MRI)

Objectif

Research and development of a new microcapsule contrast agent with unique properties for MRI of both, the blood pool and internal organs. This dual agent approach allows patients to receive quicker and more convenient diagnosis, earlier disease detection and significantly reduces health care spending. The current problem relates to multiple and cost-& time intensive diagnosis - intended to be reduced to a 'one step diagnosis' by this new technology. Within the Craft project (step 2) we expect to develop a contrast agent suitable for the initial stages of clinical testing. Expertise and know-how of the Imaging market is available within the SME consortium. A suitable company (RTD performer) with the required know-how of the microcapsule spray dry technology is already identified.

Appel à propositions

Data not available

Régime de financement

EAW - Exploratory awards

Coordinateur

GOLDHAM BIOGLAN PHARMA GMBH
Contribution de l’UE
Aucune donnée
Adresse
Am Wasserberg 11
86441 ZUSMARSHAUSEN
Allemagne

Voir sur la carte

Coût total
Aucune donnée

Participants (1)